This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Roeckel, N. Articles by Gebert, J. Search for Related Content PubMed PubMed Citation Articles by Roeckel, N. Articles by Gebert, J.

High Frequency of LMAN1 Abnormalities in Colorectal Tumors with Microsatellite Instability

¹ Department of Applied Tumor Biology, Institute of Pathology, University Hospital, Heidelberg and Molecular Medicine Partnership Unit and ² Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

Requests for reprints: Johannes Gebert, University Hospital Heidelberg, Im Neuenheimer Feld 220/221, Heidelberg, 69120 Germany. Phone: 49-6221-562878; Fax: 49-6221-565983; E-mail: johannes.gebert{at}med.uni-heidelberg.de or Juergen Kopitz, Phone: 49-6221-562683; Fax: 49-6221-565983; E-mail: juergen.kopitz{at}med.uni-heidelberg.de.

Key Words: LMAN1 • ERGIC53 • transport receptor • frameshift mutation • L-type lectin • coding microsatellite instability • colorectal cancer

Glycosyl epitopes have been identified as tumor-specific markers in colorectal tumors and various lines of evidence indicate the significance of altered synthesis, transport, and secretion of glycoproteins in tumorigenesis. However, aberrant glycosylation has been largely ignored in microsatellite unstable (MSI-H) colorectal tumors. Therefore, we analyzed mutation frequencies of genes of the cellular glycosylation machinery in MSI-H tumors, focusing on frameshift mutations in coding MNRs (cMNRs). Among 28 candidate genes, LMAN1/ERGIC53, a mannose-specific lectin mediating endoplasmatic reticulum (ER)-to-Golgi transit of glycosylated proteins, showed high mutation frequency in MSI-H colorectal cancer cell lines (52%; 12 of 23), carcinomas (45%; 72 of 161), and adenomas (40%; 8 of 20). Biallelic mutations were observed in 17% (4 of 23) of MSI-H colorectal cancer cell lines. LMAN1 was found to be transcribed but truncated protein remained undetectable in these LMAN1-mutant cell lines. Immunohistochemical and molecular analysis of LMAN1-mutated carcinomas and adenomas revealed regional loss of LMAN1 expression due to biallelic LMAN1 cMNR frameshift mutations. In LMAN1-deficient colorectal cancer cell lines, secretion of the LMAN1 client protein -1-antitrypsin (A1AT), an inhibitor of angiogenesis and tumor growth, was significantly impaired but could be restored upon LMAN1 re-expression. These results suggest that LMAN1 mutational inactivation is a frequent and early event potentially contributing to MSI-H tumorigenesis. [Cancer Res 2009;69(1):292–9]